WWOX and glioblastoma: In GBM, our data indicate low WWOX/HIF1A ratios activate multiple proliferative and survival pathways regulated by HIF1A and its cofactors, including Wnt, TGF-β, AP2α, and AP2γ, collectively driving tumour progression and resistance to apoptosis [125,136].